Literature DB >> 21431290

Addition of mizoribine to the prednisolone plus tacrolimus treatment regimen in a patient with lupus flare.

Shojiro Watanabe, Kazushi Tsuruga, Tomomi Aizawa-Yashiro, Eishin Oki, Etsuro Ito, Hiroshi Tanaka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21431290     DOI： 10.1007/s00296-011-1858-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  9 in total

1.  Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus.

Authors:  T J Lehman; K Onel
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

2.  A novel multidrug therapy for difficult cyclosporine-resistant focal segmental glomerulosclerosis.

Authors:  Eishin Oki; Kazushi Tsuruga; Masanobu Kudo; Koji Tsugawa; Koichi Suzuki; Hiroshi Tanaka
Journal:  Pediatr Nephrol       Date:  2008-10-24       Impact factor: 3.714

Review 3.  Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases.

Authors:  H Burkhardt; J R Kalden
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

4.  Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.

Authors:  C M Lanata; T Mahmood; D M Fine; M Petri
Journal:  Lupus       Date:  2010-04-13       Impact factor: 2.911

5.  Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.

Authors:  W Yumura; S Suganuma; K Uchida; T Moriyama; S Otsubo; T Takei; M Naito; M Koike; K Nitta; H Nihei
Journal:  Clin Nephrol       Date:  2005-07       Impact factor: 0.975

6.  Mizoribine attenuates renal injury and macrophage infiltration in patients with severe lupus nephritis.

Authors:  Hiroshi Tanaka; Eishin Oki; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Yuya Ito; Norihiro Sato; Yukihiko Kawasaki; Junzo Suzuki
Journal:  Clin Rheumatol       Date:  2010-05-19       Impact factor: 2.980

Review 7.  Treatment for lupus nephritis: a revisit.

Authors:  Kar Neng Lai; Sydney C W Tang; Chi Chiu Mok
Journal:  Nephrology (Carlton)       Date:  2005-04       Impact factor: 2.506

8.  Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.

Authors:  H Tanaka; E Oki; K Tsuruga; T Yashiro; I Hanada; E Ito
Journal:  Clin Nephrol       Date:  2009-12       Impact factor: 0.975

9.  Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.

Authors:  H Tanaka; E Oki; K Tsugawa; K Nonaka; K Suzuki; E Ito
Journal:  Lupus       Date:  2007       Impact factor: 2.911
  9 in total
  1 in total

Review 1.  Treatment of young patients with lupus nephritis using calcineurin inhibitors.

Authors:  Hiroshi Tanaka; Kazushi Tsuruga; Tomomi Aizawa-Yashiro; Shojiro Watanabe; Tadaatsu Imaizumi
Journal:  World J Nephrol       Date:  2012-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.